What are peptide bioregulators?
Peptide bioregulators are very short synthetic peptides, usually two to four amino acids long, that are studied for proposed tissue-specific effects on gene expression and protein synthesis in research models. The concept holds that particular short sequences are associated with particular tissues, such as neural or vascular tissue. It is a research hypothesis examined mainly in cell culture and animal models, not an established therapeutic category. Catalog examples are listed at /specialty-peptides and /cognitive-peptides.
Where did the bioregulator concept come from?
The concept is most closely associated with Vladimir Khavinson and colleagues in St. Petersburg, Russia, whose group has published on short peptide bioregulators over several decades. Much of that literature appeared in Russian-language journals and comes from a relatively small number of connected research groups. That history is worth knowing because it shapes how researchers weigh the evidence, particularly the value of independent replication by unrelated laboratories.
What is Pinealon?
Pinealon is a synthetic tripeptide from the Khavinson bioregulator family, generally described as Glu-Asp-Arg, or EDR in one-letter code. It is studied in cell culture and animal models for neuroprotective and cognitive endpoints, including resistance of neural cells to oxidative stress, and for variables related to the pineal gland and circadian regulation. Findings come from preclinical models only. Compound detail is at /peptides/pinealon. Supplied for laboratory research only.
What is Vesugen?
Vesugen is a synthetic tripeptide described as Lys-Glu-Asp, or KED, and is the vascular-tissue member of the short peptide bioregulator group. It is studied in research models for endothelial function and vessel-wall protein synthesis, reflecting the tissue-specific hypothesis behind bioregulators generally. The published work is preclinical and concentrated in a small number of research groups. Compound detail is at /peptides/vesugen. Supplied for laboratory research only.
What is Ovagen?
Ovagen is a short peptide bioregulator from the Khavinson family, described in the catalog in connection with reproductive and organ tissue-support research. Published descriptions of Ovagen's sequence and target tissue are not fully consistent across sources, so researchers should rely on the stated sequence and lot-specific analytical data rather than on the name alone. Compound detail is at /peptides/ovagen, and lot documentation is available at /coa. Supplied for laboratory research only.
Is Adamax a bioregulator?
Not in the strict sense. Adamax is described as a synthetic nootropic peptide analog in the same research family as Semax and Selank, and it is studied for neurotrophic and neuroprotective signaling, including interest in BDNF-related pathways. It is not one of the Khavinson di-, tri-, or tetrapeptides. It appears on this page because researchers frequently search for it alongside Pinealon. Compound detail is at /peptides/adamax, and related compounds are grouped at /cognitive-peptides.
How are short peptides proposed to work?
The central proposal is that short peptides can enter cells and interact with DNA or chromatin-associated proteins at specific sequences, influencing the expression of genes relevant to a particular tissue. Supporting evidence comes largely from cell culture, molecular modeling, and animal studies reported by the originating groups. The mechanism is debated, and it has not been characterized with the depth of receptor-based mechanisms such as those of GLP-1 or growth hormone secretagogue peptides.
How do bioregulators differ from receptor-agonist peptides?
Receptor-agonist peptides such as semaglutide or ipamorelin are characterized by binding to a defined cell-surface receptor and triggering a measurable signaling cascade, with binding affinities and receptor selectivity well documented. Bioregulators are proposed to act inside the cell on gene expression, and no single defined receptor explains their reported effects. That difference makes their mechanism harder to test and is one reason the evidence base is considered less mature.
How does Epithalon relate to the bioregulator family?
Epithalon, also spelled Epitalon, is generally described as the tetrapeptide Ala-Glu-Asp-Gly, or AEDG, and it comes from the same Khavinson research program. It is studied mainly in aging, telomere, and pineal-related research models, which is why it sits in the anti-aging category rather than alongside the tissue-specific tripeptides. Its profile is at /peptides/epithalon, and longer coverage is at /learn/epithalon-complete-research-profile.
What research models are used to study bioregulators?
Published work uses several model types. Cell culture studies examine gene expression, protein synthesis, and markers of cellular aging in specific cell lines. Tissue explant studies compare treated and untreated tissue fragments. Animal studies, often in aged rodents, examine tissue-specific or lifespan-related endpoints. Each model answers a narrower question than the broad claims sometimes made about bioregulators, so results should be interpreted within the limits of the model.
How strong is the evidence for bioregulator peptides?
The evidence is best described as early and concentrated. A large share of the published literature originates from the founding research groups, many studies are small, and independent replication by unrelated laboratories is limited. None of these compounds is FDA approved for any use. Researchers typically treat bioregulators as hypothesis-generating tools and design studies with appropriate controls rather than assuming effects reported elsewhere will reproduce.
Why are bioregulators so short, and does that affect stability?
Short length is part of the hypothesis, since small peptides are proposed to reach intracellular targets more readily than larger molecules. Short peptides have few residues to protect, and exopeptidases can degrade a di- or tripeptide quickly in biological fluids. In the laboratory, the dry lyophilized form is generally the most stable storage state. Handling considerations are covered at /questions/storage-and-shelf-life and /learn/lyophilized-peptides-explained.
What should a COA show for a tripeptide like Pinealon?
A useful certificate of analysis reports HPLC purity and mass spectrometry confirming the observed mass matches the expected molecular weight. There is an important caveat for tripeptides: sequence permutations such as EDR and DER contain the same amino acids and have the same mass, so a simple mass check cannot confirm residue order. Fragmentation methods such as tandem mass spectrometry, or comparison against a reference standard, add that confirmation. More at /questions/purity-testing-and-coa.
Are bioregulator peptides approved drugs?
No. None of the bioregulator peptides discussed here is FDA approved, and they are supplied in the United States strictly as research-grade reference materials for in-vitro and laboratory use. They are not for human or animal consumption and are not treatments, cosmetics, or supplements. The regulatory framing for research compounds in general is covered at /questions/legality-and-compliance.
Can a supplier advise on human use of bioregulators?
No. A research supplier provides materials and analytical documentation for laboratory work and does not provide medical, dosing, or personal-use guidance. Questions about human health, safety, or suitability of any substance should be directed to a licensed clinician. Scientific background on how peptides are studied is available throughout /learn, and general topics are collected at /questions.
How can a lab request bioregulator research materials?
Approved research accounts can request materials through /order, where availability and lot documentation are handled. Compound pages at /peptides/pinealon, /peptides/vesugen, /peptides/ovagen, and /peptides/adamax list available formats. Certificates of analysis for specific lots are available through /coa. All materials are supplied for laboratory research use only and are not for human or animal consumption.
Create a free research account to view current pricing, real-time stock, and bundles, then submit your order for approval.
More research peptide questions
How to Order and Buy Research Peptides: Ordering FAQ · Shipping and Delivery Questions · Purity, Testing, and Certificates of Analysis (COA) · Peptide Reconstitution and Research Dosing Math: Reference FAQ · Research Peptide Storage, Handling, and Shelf Life · Research Peptide Legality, Regulations, and Research-Use Compliance
All questions & answers · What are peptides? · Research guides · Order portal